Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales Soar

ToplineDanish pharma giant Novo Nordisk on Wednesday reported better-than-expected earnings for 2023, propelled by a tsunami of demand for its blockbuster weight loss and diabetes drugs as new treatments emerge and compete for a slice of the growing market.Sales of Wegovy, an injectable prescription weight loss medicine, has helped boost profits for Novo ... [+] Nordisk.UCG/Universal Images Group via Getty Images Key FactsNovo Nordisk reported $33.7 billion of sales for 2023, an increase of 36% at constant ...